Justin M. Johnson

2.0k total citations
46 papers, 1.6k citations indexed

About

Justin M. Johnson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Justin M. Johnson has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Justin M. Johnson's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Justin M. Johnson is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Justin M. Johnson collaborates with scholars based in United States, United Kingdom and Japan. Justin M. Johnson's co-authors include Vincent K. Tuohy, Min Yu, Peter M. Mathisen, Cengiz Z. Altuntas, Julie A. Kawczak, Theodore A. Stern, Andrea E. Edling, Ritika Jaini, Dan Jane‐wit and Judith Drazba and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Justin M. Johnson

45 papers receiving 1.5k citations

Peers

Justin M. Johnson

IMMUN

MB

ONCOL

NEURO

PFM

Ron H. Stead Canada

Mia Levite Israel

Mohammad A. A. Ibrahim United Kingdom

B. Tavolato Italy

Marjan A. Versnel Netherlands

Ana Silva Portugal

Pasquale Annunziata Italy

Jill Donelan United States

Marcela V. Karpuj United States

I. K. Hart United Kingdom

Ron H. Stead Canada

Justin M. Johnson

775 ×1.2

IMMUN

528 ×1.6

MB

112 ×0.5

ONCOL

177 ×0.8

NEURO

58 ×0.3

PFM

Citations per year, relative to Justin M. Johnson Justin M. Johnson (= 1×) peers Ron H. Stead

Countries citing papers authored by Justin M. Johnson

Since Specialization

Citations

This map shows the geographic impact of Justin M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin M. Johnson more than expected).

Fields of papers citing papers by Justin M. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin M. Johnson. The network helps show where Justin M. Johnson may publish in the future.

Co-authorship network of co-authors of Justin M. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Justin M. Johnson. A scholar is included among the top collaborators of Justin M. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin M. Johnson. Justin M. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Johnson, Justin M., Halle C. F. Moore, Megan Kruse, et al.. (2024). Abstract PO2-17-12: Phase I Trial of alpha-lactalbumin vaccine in high risk operable triple negative breast cancer (TNBC) and patients at high genetic risk for TNBC. Cancer Research. 84(9_Supplement). PO2–17. 1 indexed citations

2.

Budd, G. Thomas, Justin M. Johnson, Halle C. F. Moore, et al.. (2023). Abstract 3035: Phase I trial of alpha-lactalbumin vaccine in high-risk operable triple-negative breast cancer. Cancer Research. 83(7_Supplement). 3035–3035. 3 indexed citations

3.

Mazumder, Suparna, et al.. (2020). Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II. Oncotarget. 11(20). 1894–1910. 5 indexed citations

4.

Tuohy, Vincent K., Justin M. Johnson, & Suparna Mazumder. (2020). Primary immunoprevention of adult onset cancers by vaccinating against retired tissue-specific self-proteins. Seminars in Immunology. 47. 101392–101392. 5 indexed citations

5.

Johnson, Justin M. & Theodore A. Stern. (2014). Teaching Residents About Emotional Intelligence and Its Impact on Leadership. Academic Psychiatry. 38(4). 510–513. 24 indexed citations

6.

Altuntas, Cengiz Z., Ritika Jaini, Dan Jane‐wit, et al.. (2011). Autoimmune mediated regulation of ovarian tumor growth. Gynecologic Oncology. 124(1). 98–104. 6 indexed citations

7.

Altuntas, Cengiz Z., Firouz Daneshgari, Guiming Liu, et al.. (2008). Bladder dysfunction in mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 203(1). 58–63. 27 indexed citations

8.

Jane‐wit, Dan, et al.. (2007). Sex-Defined T-Cell Responses to Cardiac Self Determine Differential Outcomes of Murine Dilated Cardiomyopathy. American Journal Of Pathology. 172(1). 11–21. 8 indexed citations

9.

Park, Hyun-Min, Justin M. Johnson, Cengiz Z. Altuntas, et al.. (2006). Increased Frequencies of Cochlin-Specific T Cells in Patients with Autoimmune Sensorineural Hearing Loss. The Journal of Immunology. 177(6). 4203–4210. 80 indexed citations

10.

Solares, C. Arturo, Andrea E. Edling, Justin M. Johnson, et al.. (2004). Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. Journal of Clinical Investigation. 113(8). 1210–1217. 57 indexed citations

11.

Solares, C. Arturo, Andrea E. Edling, Justin M. Johnson, et al.. (2004). Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. Journal of Clinical Investigation. 113(8). 1210–1217. 54 indexed citations

12.

Edling, Andrea E., et al.. (2004). Human and murine lymphocyte neurotrophin expression is confined to B cells. Journal of Neuroscience Research. 77(5). 709–717. 53 indexed citations

13.

Jane‐wit, Dan, Min Yu, Andrea E. Edling, et al.. (2002). A Novel Class II-Binding Motif Selects Peptides That Mediate Organ-Specific Autoimmune Disease in SWXJ, SJL/J, and SWR/J Mice. The Journal of Immunology. 169(11). 6507–6514. 20 indexed citations

14.

Yin, Ling, Canqing Yu, Andrea E. Edling, et al.. (2001). Pre-Emptive Targeting of the Epitope Spreading Cascade with Genetically Modified Regulatory T Cells During Autoimmune Demyelinating Disease. The Journal of Immunology. 167(11). 6105–6112. 11 indexed citations

15.

Mathisen, Peter M., Julie A. Kawczak, Min Yu, Justin M. Johnson, & Vincent K. Tuohy. (2001). Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis. Journal of Neuroscience Research. 64(5). 542–551. 10 indexed citations

16.

Folcik, Virginia A, Terry J. Smith, Julie A. Kawczak, et al.. (1999). Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors. Journal of Neuroimmunology. 97(1-2). 119–128. 51 indexed citations

17.

Mathisen, Peter M., Justin M. Johnson, Julie A. Kawczak, & Vincent K. Tuohy. (1999). Visinin-like Protein (VILIP) Is a Neuron-specific Calcium-dependent Double-stranded RNA-binding Protein. Journal of Biological Chemistry. 274(44). 31571–31576. 27 indexed citations

18.

Mathisen, Peter M., Min Yu, Justin M. Johnson, Judith Drazba, & Vincent K. Tuohy. (1997). Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells. The Journal of Experimental Medicine. 186(1). 159–164. 144 indexed citations

19.

Yu, Min, Justin M. Johnson, & Vincent K. Tuohy. (1996). A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.. The Journal of Experimental Medicine. 183(4). 1777–1788. 222 indexed citations

20.

Tuohy, Vincent K., Dawn Thomas, Talat Haqqi, Min Yu, & Justin M. Johnson. (1995). Determinant-Regulated Onset of Experimental Autoimmune Encephalomyelitis: Distinct Epitopes of Myelin Proteolipid Protein Mediate Either Acute or Delayed Disease in SJL/J Mice. Autoimmunity. 21(3). 203–213. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact